Is there any emerging data demonstrating the utility of performing gene expression assays in TNBC to understand potential chemotherapy sensitivity?
Are you ever utilizing these in your own practice for TNBC?
Answer from: Medical Oncologist at Academic Institution
Chemotherapy drug-specific predictive markers have been impossible to find so far. General chemotherapy sensitivity features have been found, but are not part of any currently clinically used assay. High expression of DNA damage repair genes and high expression of immune-related genes have both been...